Teligent

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch Teligent and buy or sell other stocks, ETFs, and their options commission-free!

About TLGT

VJGJ, Inc. engages in the development, manufacture, and market of topical and branded generic and generic injectable pharmaceutical products. It also provides contract manufacturing services to the pharmaceutical, over the counter, and cosmetic markets. 

CEO
Timothy B. Sawyer
CEOTimothy B. Sawyer
Employees
Employees
Headquarters
Buena, New Jersey
HeadquartersBuena, New Jersey
Founded
1977
Founded1977
Employees
Employees

TLGT Key Statistics

Market cap
18.60K
Market cap18.60K
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
10.74K
Average volume10.74K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$0.63
52 Week high$0.63
52 Week low
$0.0001
52 Week low$0.0001

Stock Snapshot

As of today, Teligent(TLGT) shares are valued at $0.50. The company's market cap stands at 18.6K.

During the trading day, Teligent(TLGT) stock saw an opening price of —, a peak of —, and a bottom of —.

Trading volume for Teligent(TLGT) stock has reached 0, versus its average volume of 10.74K.

Over the past 52 weeks, Teligent(TLGT) stock has traded between a high of $0.63 and a low of $0.00.

Over the past 52 weeks, Teligent(TLGT) stock has traded between a high of $0.63 and a low of $0.00.

People also own

Based on the portfolios of people who own TLGT. This list is generated using Robinhood data, and it’s not a recommendation.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.